Abstract
CD44 variant 6 (CD44 v6) is well known as a useful marker of tumor progression; however, its relationship to prognosis has not yet been elucidated. In this study, we investigated the expression of CD44 v6 in colorectal cancer to analyze its relationship to hepatic metastasis as well as to prognosis. Tumor tissues were obtained from 42 patients with colorectal cancer who underwent curative resection with follow-up periods ranging from 5.9 to 71.3 months. There were 21 patients (50%) whose tumors were positive for CD44 v6, with no significant difference between colon and rectal cancer. CD44 v6 staining was significantly related to Dukes' classification as well as to hepatic metastasis. The 5-year survival rate was significantly higher in patients with CD44 v6 negative cancer (84%) than in those with CD44 v6 positive cancer (31%). Thus, we concluded that CD44 v6 could be a reliable prognostic indicator, as well as a predictor of metastatic potential after curative surgery for colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
References
Günthert U, Hofman M, Rudy W, Reber S, Zöller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrilich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 66:13–24
Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053–1058
Wielenga VJM, Heider KH, Offerhaus JA, Günther RA, van den Berg F, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53:4754–4756
Mulder JWR, Wielenga VJM, Polak MM, van den Berg F, Günther RA, Herrlich P, Pals ST, Offerhaus JA (1995) Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 36:76–80
Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227–233
Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160–12164
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nihei, Z., Ichikawa, W., Kojima, K. et al. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer. Surg Today 26, 760–761 (1996). https://doi.org/10.1007/BF00312104
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00312104